Healthcare
A new method for materials simulation
July 28, 2017 | Written by: IBM Research Editorial Staff
Categorized: Healthcare | STFC-Hartree Center
Share this post:
The ability to predict the properties of materials before they are fabricated, or to explore their behavior under conditions which are impractical to replicate under laboratory conditions (eg extreme temperatures or pressures) is critical for next generation materials design. Improving the predictive power of materials modelling guides planning and design, saves money, and can accelerate discovery.
Video credit: Flaviu Cipcigan
![Conventional ball and stick model of the sucrose molecule [Source: http://www.gustrength.com/glossary:compound]](https://www.ibm.com/blogs/research/wp-content/uploads/2017/07/Figure-1.png)
Conventional ball and stick model of the sucrose molecule [Source]
As an added problem, simulating molecules is even more difficult when dealing with outside influences, such as when the molecule is in a solution, encapsulated (such as when used to aid drug delivery), tagged with other molecules, or in contact with a cell surface. Coping with such a wide range of conditions presents fundamental challenges for current methodologies which tend to be designed to cope with a single, average, environment rather than adapt to changing circumstances.
IBM researchers, in conjunction with the Hartree Centre have developed a fundamentally new strategy for capturing these electronic effects in molecules, which can predict the weird properties of water – from the freezing point to the critical point (when water’s liquid and vapor states can coexist) and beyond. The approach – called “electronic coarse graining” – represents the electron cloud bound to a molecule as a single charged object tethered to the molecular frame by a spring. The simplicity of the “electronic coarse graining” approach captures the full spectrum of intermolecular forces, including those that arise from dispersion and polarization, which are typically not included in conventional models.

An example of the model created when using the new, “electronic corse graining” approach
A particularly challenging and important area for this type of research is in the life sciences and biotechnology space, where the development pipeline for new drugs and compounds is often long and costly – and molecular-level insight is priceless. Here, it is essential to understand the structure and simulations of elements at the molecular scale in a variety of complex and changing environments, as the molecular structure of drug design is critical to their effectiveness.
This work lays the foundation for much more predictive, and reliable materials modelling involving fewer assumptions, and taking into account a much more complete set of molecular forces. The method will be extended first in life sciences and simple biomolecules and eventually on to short proteins and self-assembling structures. All of these circumstances are relevant to the drug discovery cycle from early design concepts, understanding mode of action at the molecular scale, through to the development of a new medicine.
Sources
Electronic coarse graining enhances the predictive power of molecular simulation allowing challenges in water physics to be addressed –Journal of Computational Physics 326, 222-233
Molecular-scale remnants of the liquid-gas transition in supercritical polar fluids – Physical Review Letters 115 (11), 117801
Signature properties of water: Their molecular electronic origins – Proceedings of the National Academy of Sciences 112 (20), 6341-6346
AI helps explain your microbiome
Newly published research describes an Explainable AI to help understand the link between skin microbiome composition and personal wellbeing.
COVID-19 a year later: What have we learned?
We’ve learned a lot during the past year about how to address global crises, but in my mind, one lesson cannot be ignored: The need for more strategic collaborations across institutions and sectors.
AI to help doctors develop personalized treatments
IBM researchers have created an AI-powered software to help doctors develop personalized treatments for different patients with the exact same diagnosis.